Literature DB >> 9227714

Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients.

G A Finlay1, K J Russell, K J McMahon, E M D'arcy, J B Masterson, M X FitzGerald, C M O'Connor.   

Abstract

BACKGROUND: Matrix degradation in emphysema has long been attributed to the action of neutrophil elastase (NE). More recently a role for other proteases, particularly the matrix metalloproteinases (MMPs), in the pathogenesis of this disease has been proposed. To date, however, the presence of MMPs in the lungs of patients with emphysema has not been demonstrated.
METHODS: Samples of bronchoalveolar lavage (BAL) fluid from 10 patients with emphysema and from control subjects matched for sex and current smoking status were assessed for collagenase, gelatinase, and NE activity. Pulmonary function tests and computed tomographic (CT) scans were carried out on all study subjects.
RESULTS: Collagenase activity was detected in BAL fluid samples from all emphysematous patients but in only one smoking control (p < 0.001). Gelatinase B was present in six patients and in two smoking controls (p < 0.03). The concomitant presence of gelatinase B in complex with lipocalin (NGAL) in the gelatinase positive samples suggests that the neutrophil is a significant source of the gelatinase B observed. NE was detected in six of the 10 patients with emphysema and in two smoking controls (p < 0.01), indicating that collagenase was more useful in discriminating between disease and control groups than either NE or gelatinase B. No relationship was observed between any of the enzymes measured and pulmonary function or CT density score.
CONCLUSIONS: This study demonstrates, for the first time, the presence of increased levels of matrix metalloproteinases in the lungs of patients with emphysema and suggests that, in BAL fluid, collagenase activity may be a better indicator of the presence of emphysema than elastase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9227714      PMCID: PMC1758576          DOI: 10.1136/thx.52.6.502

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  10 in total

Review 1.  Emphysema: the first two centuries--and beyond. A historical overview, with suggestions for future research: Part 2.

Authors:  G L Snider
Journal:  Am Rev Respir Dis       Date:  1992-12

2.  Granulocyte collagenase: selective digestion of type I relative to type III collagen.

Authors:  A L Horwitz; A J Hance; R G Crystal
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

3.  Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution.

Authors:  S I Rennard; G Basset; D Lecossier; K M O'Donnell; P Pinkston; P G Martin; R G Crystal
Journal:  J Appl Physiol (1985)       Date:  1986-02

4.  Asthma and the common cold: can viruses imitate worms?

Authors:  P J Openshaw; D R O'Donnell
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

5.  Levels of elastase activity in bronchoalveolar lavage fluids of healthy smokers and nonsmokers.

Authors:  A Janoff; L Raju; R Dearing
Journal:  Am Rev Respir Dis       Date:  1983-05

6.  Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase.

Authors:  M S Hibbs; K A Hasty; J M Seyer; A H Kang; C L Mainardi
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

7.  Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis.

Authors:  C O'Connor; C Odlum; A Van Breda; C Power; M X Fitzgerald
Journal:  Thorax       Date:  1988-05       Impact factor: 9.139

Review 8.  New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: its role in lung disease.

Authors:  T D Tetley
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

9.  Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema.

Authors:  J D'Armiento; S S Dalal; Y Okada; R A Berg; K Chada
Journal:  Cell       Date:  1992-12-11       Impact factor: 41.582

Review 10.  Health effects of cigarette smoking.

Authors:  C B Sherman
Journal:  Clin Chest Med       Date:  1991-12       Impact factor: 2.878

  10 in total
  69 in total

Review 1.  Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

Review 2.  Chronic obstructive pulmonary disease - part 2: pathology and biochemistry of emphysema.

Authors:  J C Hogg; R M Senior
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

3.  Serum cystatin C and emphysema: results from the National Health and Nutrition Examination Survey (NHANES).

Authors:  Haala K Rokadia; Shikhar Agarwal
Journal:  Lung       Date:  2012-06       Impact factor: 2.584

4.  Emphysema in COPD: consequences and causes.

Authors:  G M Turino
Journal:  Thorax       Date:  2006-12       Impact factor: 9.139

Review 5.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 6.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

7.  Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity.

Authors:  B C Finzel; E T Baldwin; G L Bryant; G F Hess; J W Wilks; C M Trepod; J E Mott; V P Marshall; G L Petzold; R A Poorman; T J O'Sullivan; H J Schostarez; M A Mitchell
Journal:  Protein Sci       Date:  1998-10       Impact factor: 6.725

Review 8.  New therapies for chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

9.  The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation.

Authors:  Matthew T Hardison; F Shawn Galin; Christopher E Calderon; Uros V Djekic; Suzanne B Parker; Keith M Wille; Patricia L Jackson; Robert A Oster; K Randall Young; J Edwin Blalock; Amit Gaggar
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

Review 10.  Interfering with extracellular matrix degradation to blunt inflammation.

Authors:  Philip J O'Reilly; Amit Gaggar; J Edwin Blalock
Journal:  Curr Opin Pharmacol       Date:  2008-03-17       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.